EMD-62629

Single-particle
2.71 Å
EMD-62629
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62629

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9kxv summary report (pdf.gz) Map-9kxv FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of human B0AT1-ACE2 complex with compound3

EMD-62629

Single-particle
2.71 Å
EMD-62629
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Ternary complex of B0AT1, ACE2 and inhibitor
Fitted models: 9kxv

Deposition Authors: Imazu T , Miyaguchi I, Hiraizumi M

Structure-guided development of a potent human B0AT1 inhibitor effective in a mouse model of phenylketonuria
Imazu T , Akashi T , Hiraizumi M , Inui Y, Sasaki W, Takahashi T, Todoroki H, Kumanomidou T, Hisano H, Asada H, Kusakizako T, Nishizawa T, Iwata S , Nureki O , Miyaguchi I
To Be Published
Grant Support: